Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Enrico, Maffini"'
Autor:
Margherita Ursi, Katarzyna Malgorzata Kwiatkowska, Chiara Pirazzini, Gianluca Storci, Daria Messelodi, Salvatore Nicola Bertuccio, Serena De Matteis, Francesco Iannotta, Enrica Tomassini, Marcello Roberto, Maria Naddeo, Noemi Laprovitera, Irene Salamon, Barbara Sinigaglia, Elisa Dan, Francesco De Felice, Francesco Barbato, Enrico Maffini, Sadia Falcioni, Mario Arpinati, Manuela Ferracin, Massimiliano Bonafè, Paolo Garagnani, Francesca Bonifazi
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/74b6fe4ee1dd4ba0a43eb78aa91ae164
Autor:
Michele Malagola, MD, Nicola Polverelli, MD, Massimo Martino, MD, Francesca Patriarca, MD, Benedetto Bruno, MD, Luisa Giaccone, MD, Giovanni Grillo, MD, Stefania Bramanti, MD, Paolo Bernasconi, MD, Marco De Gobbi, MD, Annalisa Natale, MD, Elisabetta Terruzzi, MD, Attilio Olivieri, MD, Patrizia Chiusolo, MD, Angelo Michele Carella, MD, Marco Casini, MD, Enrico Maffini, MD, Chiara Nozzoli, MD, Patrizio Mazza, MD, Simona Bassi, Francesco Onida, MD, Adriana Vacca, MD, Sadia Falcioni, MD, Mario Luppi, MD, Anna Paola Iori, MD, Vincenzo Pavone, MD, Cristina Skert, MD, Paola Carluccio, MD, Carlo Borghero, MD, Anna Proia, MD, Carmine Selleri, MD, Vicky Rubini, MD, Nicoletta Sacchi, MD, Elena Oldani, MD, Francesca Bonifazi, MD, Fabio Ciceri, MD, Domenico Russo, MD, Simona Bernardi, Mirko Farina, Maria Fiore, Maria Teresa Lupo Stanghellini, Renato Fanin, Danilo Giuseppe Faraci, Luca Castagna, Anna Amelia Colombo, Paolo Nicoli, Stella Santarone, Ilaria Scortechini, Elisabetta Metafuni, Emanuela Merla, Irene Cavattoni, Ilaria Cutini, Annamaria Mazzone, Giorgia Saporiti, Filippo Antonio Canale, Eugenia Piras, Piero Galieni, Giulia Debbia, Ursula La Rocca, Anna Mele, Francesca Carobolante, Francesca Elice, Fulvia Fanelli
Publikováno v:
Transplantation Direct, Vol 9, Iss 3, p e1451 (2023)
Background. The conditioning regimens with different alkylators at different doses can influence the outcome of allogeneic stem cell transplantation (SCT), but conclusive data are missing. Methods. With the aim to analyze real-life allogeneic SCTs pe
Externí odkaz:
https://doaj.org/article/f52ad82b2231458eb6e334ecb921fb0f
Autor:
Gianluca Storci, Francesco Barbato, Francesca Ricci, Pier Luigi Tazzari, Serena De Matteis, Enrica Tomassini, Michele Dicataldo, Noemi Laprovitera, Mario Arpinati, Margherita Ursi, Enrico Maffini, Elena Campanini, Elisa Dan, Silvia Manfroi, Spartaco Santi, Manuela Ferracin, Massimiliano Bonafe, Francesca Bonifazi
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
Graft versus host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). Rabbit anti-T lymphocyte globulin (ATLG) in addition to calcineurin inhibitors and antimetabolites is a suitable strategy to preven
Externí odkaz:
https://doaj.org/article/9b23d25c5ac64b439d100ce826930ffc
Autor:
Serena De Matteis, Michele Dicataldo, Beatrice Casadei, Gianluca Storci, Noemi Laprovitera, Mario Arpinati, Enrico Maffini, Pietro Cortelli, Maria Guarino, Francesca Vaglio, Maria Naddeo, Barbara Sinigaglia, Luca Zazzeroni, Serafina Guadagnuolo, Enrica Tomassini, Salvatore Nicola Bertuccio, Daria Messelodi, Manuela Ferracin, Massimiliano Bonafè, Pier Luigi Zinzani, Francesca Bonifazi
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundInfusion of second generation autologous CD19-targeted chimeric antigen receptor (CAR) T cells in patients with R/R relapsed/refractory B-cell lymphoma (BCL) is affected by inflammatory complications, such as Immune Effector Cell-Associated
Externí odkaz:
https://doaj.org/article/f9964366181e4ab280f57b54a8321f14
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind pregnancy-related and infection-related forms. Although the list of drugs potentiall
Externí odkaz:
https://doaj.org/article/682e0fd3c0fc43689634d08413fbc596
Autor:
Enrico Maffini, Margherita Ursi, Francesco Barbato, Michele Dicataldo, Marcello Roberto, Elena Campanini, Elisa Dan, Francesco De Felice, Serena De Matteis, Gianluca Storci, Massimiliano Bonafè, Mario Arpinati, Francesca Bonifazi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Disease relapse represents by far the most frequent cause of hematopoietic cell transplantation (HCT) failure. Patients with acute leukemia suffering relapse after HCT have limited conventional treatment options with little possibility of cure and re
Externí odkaz:
https://doaj.org/article/cabac83eed3f466cbfedca9e382d76b9
Autor:
Marco Cerrano, Marco Ruella, Miguel-Angel Perales, Candida Vitale, Danilo Giuseppe Faraci, Luisa Giaccone, Marta Coscia, Molly Maloy, Miriam Sanchez-Escamilla, Hesham Elsabah, Afraa Fadul, Enrico Maffini, Gianfranco Pittari, Benedetto Bruno
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabt
Externí odkaz:
https://doaj.org/article/69eebbaf67934dfbb8ff1101f08ddda1
Autor:
Enrico Maffini, Myriam Labopin, Dietrich Wilhelm Beelen, Nicolaus Kroeger, Mutlu Arat, Keith M. O. Wilson, Jacques-Olivier Bay, Arnold Ganser, Hans Martin, Jakob Passweg, Panagiotis D. Kottaridis, Ibrahim Yakoub-Agha, Rocio Parody Porras, Eva Maria Wagner, Jordi Esteve, Francesco Lanza, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation. 57:1556-1563
Measurable residual disease (MRD) assessment before allogeneic hematopoietic cell transplantation (HCT) may help physicians to identify a subgroup of patients at high risk of relapse for de novo acute myeloid leukemia (AML) but its relevance among pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7587185aa8fee40f781de8f97fc7335b
https://doi.org/10.1038/s41409-022-01748-w
https://doi.org/10.1038/s41409-022-01748-w
Publikováno v:
Clinical Hematology International, Vol 1, Iss 2 (2019)
The majority of adult patients affected by B-cell acute lymphoblastic leukemia (B-ALL) will relapse after an initial response, while approximately 20% will display primary resistant disease. Patients suffering from relapsed/refractory B-ALL have a ve
Externí odkaz:
https://doaj.org/article/3d99637bb3904d15b2a402dcabddaa27
Autor:
Enrico Maffini, Barry E. Storer, Brenda M. Sandmaier, Benedetto Bruno, Firoozeh Sahebi, Judith A. Shizuru, Thomas R. Chauncey, Parameswaran Hari, Thoralf Lange, Michael A. Pulsipher, Peter A. McSweeney, Leona Holmberg, Pamela S. Becker, Damian J. Green, Marco Mielcarek, David G. Maloney, Rainer Storb
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
We previously reported initial results in 102 multiple myeloma (MM) patients treated with sequential high-dose melphalan and autologous hematopoietic cell transplantation followed by 200 cGy total body irradiation with or without fludarabine 90 mg/m2
Externí odkaz:
https://doaj.org/article/16ae65b124174a7db168e63d44d26e82